Research Associate specializing in equity research at Wolfe Research
Dean Rosales is a Research Associate specializing in equity research at Wolfe Research LLC, contributing to the analysis of key sectors with a particular focus on company-specific performance. He holds an undergraduate degree from Boston College and an MBA from D'Amore-McKim School of Business, reflecting strong academic credentials. Rosales maintains a FINRA registration through Wolfe Research Securities and has established a significant professional network. His role encompasses detailed coverage and analysis leveraging advanced financial and market insight, supported by a solid foundation in finance and business administration.
Dean Rosales from Wolfe Research questioned if the full-year guidance for revenue per treatment (RPT) growth of 4.5% to 5.5% remains intact.
CFO Joel Ackerman confirmed there is no change to the full-year RPT guidance. He noted that while they expect slightly more contribution from oral phosphate binders, the overall forecast remains within the previously stated range.